A Preview Of scPharmaceuticals's Earnings
Portfolio Pulse from Benzinga Insights
scPharmaceuticals (NASDAQ:SCPH) is scheduled to release its quarterly earnings report on March 13, 2024, with an expected EPS of $-0.42. The company's past earnings performance shows a mixed impact on its stock price, with the last quarter's miss resulting in an 8.74% drop. Shares are currently trading at $5.28, down 24.53% over the last year. Investors are looking for positive guidance for the next quarter.
March 12, 2024 | 3:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
scPharmaceuticals is expected to report an EPS of $-0.42 for the upcoming quarter. Historical data shows significant stock price movement post-earnings, with a notable 8.74% drop after last quarter's miss. The stock has been down 24.53% over the past year.
Given SCPH's history of stock price volatility post-earnings and the significant drop after the last quarter's miss, the upcoming earnings report is crucial. However, the expectation of an EPS of $-0.42, combined with the stock's recent performance, suggests a cautious outlook. The focus will be on the company's future guidance, which could sway the stock price more significantly than the earnings result itself.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100